Health Condition 1: M109- Gout, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged between 25 to 70 years. Both male and female patients. Clinically diagnosed cases of Vatarakta. Serum uric acid: Males 7 to 12 mg per dL and Females 6 to 12 mg per dL. Presence of at least two symptoms such as joint pain, swelling, stiffness, tenderness, or burning sensation
Exclusion criteria
Exclusion criteria: Chronic renal failure. Pregnant and lactating women. Rheumatoid arthritis. HIV or HBsAg positive patients. Chronic alcoholism. Peripheral vascular disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in serum uric acid level from baseline to Day 45 and reduction in clinical symptoms such as joint pain, swelling, stiffness, tenderness, and burning sensation. Timepoint: baseline and day 45 | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in use of rescue medication, improvement in patient quality of life, and assessment of adverse events.Timepoint: Baseline,day45,and during follow up if applicable;improvement in clinical symptoms of vataraktaTimepoint: baseline and day 45 | — |
Countries
India
Contacts
APMS ayurved mahavidyalaya,sion